Literature DB >> 17372094

Adalimumab treatment for pyoderma gangrenosum.

Michael P Heffernan1, Milan J Anadkat, David I Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17372094     DOI： 10.1001/archderm.143.3.306

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  11 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

Review 2.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

3.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

4.  Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.

Authors:  F Argüelles-Arias; L Castro-Laria; T Lobatón; M Aguas-Peris; M Rojas-Feria; M Barreiro-de Acosta; P Soto-Escribano; M Calvo-Moya; D Ginard-Vicens; M Chaparro-Sánchez; M Hernández-Durán; B Castro-Senosiain; A Fernández-Villaverde; V García-Sánchez; E Domínguez-Muñoz; A Caunedo-Álvarez; J M Herrerías-Gutiérrez
Journal:  Dig Dis Sci       Date:  2013-07-05       Impact factor: 3.199

5.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

6.  Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone.

Authors:  Eva Zold; Arpad Nagy; Katalin Devenyi; Margit Zeher; Zsolt Barta
Journal:  World J Gastroenterol       Date:  2009-05-14       Impact factor: 5.742

Review 7.  Adalimumab in dermatology.

Authors:  Pawel Traczewski; Lidia Rudnicka
Journal:  Br J Clin Pharmacol       Date:  2008-07-11       Impact factor: 4.335

8.  Bilateral lower extremity ulcerations, less is more.

Authors:  Kathryn Mooneyham Potter; Garrett Ruth; Nila S Radhakrishnan
Journal:  Clin Case Rep       Date:  2019-01-09

9.  Adalimumab: a treatment option for pyoderma gangrenosum after failure of systemic standard therapies.

Authors:  Louisa Hinterberger; Cornelia S L Müller; Thomas Vogt; Claudia Pföhler
Journal:  Dermatol Ther (Heidelb)       Date:  2012-05-12

10.  Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study.

Authors:  Kenshi Yamasaki; Keiichi Yamanaka; Yiwei Zhao; Shunsuke Iwano; Keiko Takei; Koji Suzuki; Toshiyuki Yamamoto
Journal:  J Dermatol       Date:  2020-08-17       Impact factor: 4.005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.